Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19488 | 26525342 | Physiology (Bethesda) | Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism. | 2015 | Details |
| A19495 | 26523205 | World J Hepatol | Dietary approach in the treatment of nonalcoholic fatty liver disease. | 2015 | Details |
| A19500 | 26518991 | Transl Res | Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in guinea pigs. | 2015 | Details |
| A19503 | 26517932 | Biochem Soc Trans | The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations. | 2015 | Details |
| A19521 | 26512643 | Int J Mol Sci | Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A19536 | 26503843 | Liver Int | The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. | 2015 | Details |
| A19538 | 26502288 | Gynecol Endocrinol | Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS. | 2015 | Details |
| A19544 | 26498267 | Environ Toxicol Pharmacol | Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. | 2015 | Details |
| A19545 | 26496770 | Acta Diabetol | Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components. | 2015 | Details |
| A19548 | 26494962 | World J Gastroenterol | Endocrine causes of nonalcoholic fatty liver disease. | 2015 | Details |
| A19551 | 26494024 | Nutr Res Rev | Murine models provide insight to the development of non-alcoholic fatty liver disease. | 2015 | Details |
| A19558 | 26486292 | Arq Gastroenterol | INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. | 2016 | Details |
| A19560 | 26485614 | Endocrinology | The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice. | 2015 | Details |
| A19562 | 26485433 | PLoS One | 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats. | 2015 | Details |
| A19565 | 26482965 | Diabetes Metab Syndr | Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD. | 2015 | Details |
| A19572 | 26476631 | Eur J Nutr | A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. | 2016 | Details |
| A19573 | 28962484 | Toxicol Rep | Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat. | 2015 | Details |
| A19581 | 26473614 | Hepatology | Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease. | 2015 | Details |
| A19585 | 26473136 | Pediatr Gastroenterol Hepatol Nutr | Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19589 | 26471014 | Food Funct | Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet. | 2016 | Details |
| A19592 | 26468154 | Curr Diab Rep | Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin. | 2015 | Details |
| A19594 | 26464753 | World J Hepatol | Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. | 2015 | Details |
| A19601 | 26462866 | Diabetes Obes Metab | Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis. | 2015 | Details |
| A19607 | 26461295 | Free Radic Biol Med | The effect of Irisin on antioxidant system in liver. | 2014 | Details |
| A19610 | 26458397 | BMC Med Genet | MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study. | 2015 | Details |
| A19622 | 26450277 | Br J Nutr | Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH). | 2015 | Details |
| A19635 | 26445592 | Nutr Metab (Lond) | Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1. | 2015 | Details |
| A19636 | 26444696 | Liver Int | Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. | 2015 | Details |
| A19637 | 26444605 | Clin Hemorheol Microcirc | Association of whole blood viscosity with non-alcoholic fatty liver disease. | 2015 | Details |
| A19638 | 26444279 | Clin Exp Pharmacol Physiol | Increased ratio of neutrophil elastase to α1-antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis. | 2016 | Details |
| A19645 | 26439744 | PLoS One | Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A19646 | 26439042 | Eur Rev Med Pharmacol Sci | Insulin sensitivity indices: fasting versus glucose-stimulated ındices in pediatric non-alcoholic fatty liver disease. | 2015 | Details |
| A19648 | 26438057 | Biometals | Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload. | 2015 | Details |
| A19649 | 26438035 | BMC Complement Altern Med | Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity. | 2015 | Details |
| A19654 | 26435078 | Metabolism | The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. | 2015 | Details |
| A19657 | 26433072 | Mol Cell Endocrinol | Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. | 2015 | Details |
| A19660 | 26430826 | J Am Coll Nutr | Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial. | 2015 | Details |
| A19669 | 26425466 | Indian J Endocrinol Metab | Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. | 2015 | Details |
| A19670 | 26424731 | Clin Sci (Lond) | Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19671 | 26423681 | Biochem Genet | Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes. | 2015 | Details |
| A19672 | 26423094 | J Endocrinol | Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. | 2015 | Details |
| A19674 | 26420011 | Environ Health | Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study. | 2015 | Details |
| A19676 | 26419119 | Expert Opin Ther Targets | Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. | 2015 | Details |
| A19678 | 28294798 | Kardiologiia | [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. | 2015 | Details |
| A19681 | 26416722 | Arch Biochem Biophys | MicroRNAs in obesity-associated disorders. | 2015 | Details |
| A19684 | 26412465 | Curr Pharm Des | Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome. | 2015 | Details |
| A19685 | 26411937 | Nihon Eiseigaku Zasshi | [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis]. | 2015 | Details |
| A19690 | 26408054 | Contemp Clin Trials | The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study. | 2015 | Details |
| A19691 | 26407715 | Diabetologia | Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2015 | Details |
| A19693 | 26406351 | J Dig Dis | Nonalcoholic fatty liver disease - current status and future directions. | 2015 | Details |
| A19698 | 26405708 | J Gastrointestin Liver Dis | Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity? | 2015 | Details |
| A19699 | 26405701 | J Gastrointestin Liver Dis | The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19701 | 26405614 | Cardiovasc Endocrinol | Relevance of low testosterone to non-alcoholic fatty liver disease. | 2015 | Details |
| A19704 | 26404062 | Diabetologia | A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. | 2015 | Details |
| A19706 | 26402655 | Transpl Int | Liver transplantation for nonalcoholic steatohepatitis in young patients. | 2016 | Details |
| A19713 | 26398456 | Eur J Gastroenterol Hepatol | Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus. | 2015 | Details |
| A19719 | 26395746 | Int J Obes (Lond) | A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. | 2015 | Details |
| A19723 | 26394730 | Endocrinol Metab (Seoul) | Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study. | 2015 | Details |
| A19727 | 26394161 | J Hepatol | Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. | 2015 | Details |
| A19736 | 26385233 | QJM | Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2015 | Details |
| A19737 | 26383163 | Cancer Res | Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma. | 2015 | Details |
| A19740 | 26380042 | World J Hepatol | Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how? | 2015 | Details |
| A19751 | 26378642 | Semin Liver Dis | Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD. | 2015 | Details |
| A19752 | 26378641 | Semin Liver Dis | Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander. | 2015 | Details |
| A19763 | 26367736 | Eur Rev Med Pharmacol Sci | Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. | 2015 | Details |
| A19768 | 26363598 | Curr Diab Rep | Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Obesity-Related Traits. | 2015 | Details |
| A19774 | 26358367 | Sci Rep | Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs. | 2015 | Details |
| A19777 | 26356502 | PLoS One | Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State. | 2015 | Details |
| A19781 | 26355033 | Sci Transl Med | Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. | 2015 | Details |
| A19787 | 26349165 | Trop Gastroenterol | Nonalcoholic Fatty Liver Disease--The Clinician's Perspective. | 2015 | Details |
| A19798 | 26343077 | Med Ultrason | Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A19803 | 26340970 | Eur J Endocrinol | Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease. | 2015 | Details |
| A19819 | 26328027 | World J Hepatol | Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. | 2015 | Details |
| A19820 | 26328025 | World J Hepatol | From the stomach to other organs: Helicobacter pylori and the liver. | 2015 | Details |
| A19833 | 26317347 | PLoS One | Suppressive Role of PPARγ-Regulated Endothelial Nitric Oxide Synthase in Adipocyte Lipolysis. | 2015 | Details |
| A19834 | 26316717 | Drug Des Devel Ther | Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. | 2015 | Details |
| A19835 | 26316434 | J Clin Res Pediatr Endocrinol | Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19836 | 26316333 | Sci Rep | GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance. | 2015 | Details |
| A19842 | 26314837 | J Gastroenterol | Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. | 2015 | Details |
| A19848 | 26310987 | Int J Cardiol | Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. | 2015 | Details |
| A19849 | 28943619 | Diseases | MOGAT2: A New Therapeutic Target for Metabolic Syndrome. | 2015 | Details |
| A19852 | 26305052 | Biochem Cell Biol | Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol. | 2015 | Details |
| A19859 | 26300958 | Chin Med | Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model. | 2015 | Details |
| A19860 | 26300331 | J Nutr Biochem | Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. | 2015 | Details |
| A19867 | 26297911 | Biochem Pharmacol | A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. | 2015 | Details |
| A19872 | 26292849 | Br J Pharmacol | Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes. | 2015 | Details |
| A19876 | 26290284 | Front Med | Molecular mechanisms of fatty liver in obesity. | 2015 | Details |
| A19878 | 26289505 | Niger J Clin Pract | Nonalcoholic fatty liver disease: Synopsis of current developments. | 2016 | Details |
| A19892 | 26281176 | Eksp Klin Gastroenterol | [ALLELES C282Y AND H63D HFE GENE, INSULIN RESISTANCE AND SUSCEPTIBILITY TO DISTURBANCE OF PORPHYRIN METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2015 | Details |
| A19893 | 26280342 | FP Essent | Metabolic Syndrome: Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19900 | 26278350 | Diabetes Res Clin Pract | Country of birth modifies the association of fatty liver index with insulin action in Middle Eastern immigrants to Sweden. | 2015 | Details |
| A19905 | 26273621 | Biomed Res Int | Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. | 2015 | Details |
| A19907 | 26273604 | Biomed Res Int | The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19908 | 26273598 | Biomed Res Int | Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis. | 2015 | Details |
| A19913 | 26271188 | Int J Obes (Lond) | Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. | 2015 | Details |
| A19917 | 26269440 | Zhonghua Nei Ke Za Zhi | [The impact of non-alcoholic fatty liver disease on islet function in type 2 diabetes]. | 2015 | Details |
| A19918 | 26269425 | Sci Rep | Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort. | 2015 | Details |
| A19921 | 26264980 | J Endocrinol | Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity. | 2015 | Details |
| A19925 | 26262841 | J Agric Food Chem | Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development. | 2015 | Details |
| A19926 | 26261693 | World J Hepatol | Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. | 2015 | Details |